This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Regeneron Pharmaceuticals Inc. (REGN) slid 1.88% to $706.11 Thursday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index falling 1.48% to 4,393.66 and Dow Jones Industrial Average falling 1.05% to 34,792.76. Regeneron Pharmaceuticals Inc. closed $41.31 below its 52-week high ($747.42), which the company reached on April 8th.
The stock underperformed when compared to some of its competitors Thursday, as Johnson & Johnson (JNJ) fell 0.29% to $183.36, Novartis AG ADR (NOVN.EB) fell 1.41% to $89.95, and Amgen Inc. (AMGN) rose 0.03% to $255.46. Trading volume (535,113) remained 136,420 below its 50-day average volume of 671,533.
Data source: Dow Jones Market Data, FactSet. Data compiled April 21, 2022.
(END) Dow Jones Newswires
April 22, 2022 07:51 ET (11:51 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.